Next-Generation Superfruits
Report description
This report examines the emerging market of superfruits within the global food and drinks market, analyzing data from four metrics: product launches, patent applications, health claim applications, and clinical trial data. This will enable manufacturers to assess the emerging trends and growth opportunities within the superfruit food and drinks landscape.
- Use patent application data to see which superfruits are provoking the most interest in terms of research and what is being deemed patentable.
- Use product launch data to identify the target areas for existing superfruit-based products. Understand the product breakdown by category.
- Assess EFSA's opinions and understand what types of claims are being made about which superfruits.
- Identify three up-and-coming superfruits as “ones to watch” in the future.
Blueberry and pomegranate are the most popular superfruits in new food and drink launches. But novel fruits are gaining ground, with chokeberry, jujube, and seabuckthorn being notable examples. Over 400 new food and drink products containing seabuckthorn were launched in 2009–12, the majority of which hit shelves in Russia, Germany, and France.
A high proportion of health claims involving superfruits have been specifically about antioxidants, with over one in 10 claims submitted to EFSA addressing antioxidant properties. Although many superfruit ingredients have been lauded for their cellular protection properties, only acerola is associated with an endorsed health claim by EFSA.
According to the Cochrane Library, a significant 63% of clinical trials undertaken on superfruits in the period 2009 to 2012 were able to establish a cause and effect relationship. This should prompt further testing in future to establish the positive roles superfruits play in managing certain health conditions.
- What are the more unusual superfruits that have potential to be successfully applied to food and drinks products?
- What health claims are being made about superfruits and how will these impact food and drinks players?
- What clinical trials are being undertaken on superfruits and how can these be useful to food and drinks companies?
- What patent applications have recently been filed on these superfruits and what will be the impact on their FMCG usage?
- How will regulations impact the sale of these superfruits in global markets?
Table of contents
EXECUTIVE SUMMARY
•The product launch landscape
•The patent landscape
•The health claims landscape
•The clinical trials landscape
Introduction
•What is this report about
•Defining superfruits
•Methodology
•Report structure
The product launch landscape
•Summary
•Introduction
•Leading superfruit ingredients in NPD
•Novel superfruit ingredients in NPD
Chokeberry
Jujube
Seabuckthorn
•New product category analysis
•Claims analysis in new product launches
Anti-infective
Cardiovascular
Digestive health
Metabolic disorders
•Conclusions
The patent landscape
•Summary
•Introduction
•Superfruit patent applications
Tier one
Tier two
Tier three
•Patents by therapeutic health area
•Conclusions
The health claims landscape
•Summary
•Introduction
•EFSA now has stricter controls on functional food claims
•Analysis of superfruit health claims from EFSA
Scientific opinion
•Leading therapeutic areas of claim submissions
•Conclusions
The clinical trials landscape
•Summary
•Introduction
•Existing clinical evidence for superfruits
•Most popular therapeutic areas for superfruit clinical trials
•Conclusions
Conclusions
•Key superfruits
•Current market landscape summary
•Key targeted therapeutic areas
•Superfruits: ones to watch
Mangosteen
Papaya
Seabuckthorn
•Conclusions
Appendix
•Methodology
•Glossary/abbreviations
•Bibliography/references
TABLES
•Table: Superfruits covered in this report
•Table: Leading superfruits in new food and drinks, by percentage of superfruit launches, 2009–12
•Table: Leading superfruits in new food and drinks, by percentage of the 30 superfruits analyzed in this report, 2009–12
•Table: Targeted therapeutic areas by health claims on new product launches (%), 2009–12
•Table: Patent applications in 2010 related to tier one superfruits
•Table: Acerola related patent applications, 2005–11
•Table: Tier three superfruits: No patent applications related to food and drink
•Table: Digestive health and metabolic therapeutic areas related to superfruit patent applications
•Table: EFSA negative opinions for superfruit health claims, 2011
•Table: Targeted therapeutic areas by health claims submitted to EFSA, 2009–12
•Table: Superfruit status by clinical trials, 2009–12
•Table: Targeted health areas of clinical trials, 2009–12
•Table: Future opportunities in superfruits as indicated by successful clinical trials, 2009–12
•Table: Patent applications for mangosteen, in food and drinks, 2005–12
•Table: Health claim applications for mangosteen, 2009–12
•Table: Clinical trials involving mangosteen, 2009–10
•Table: Patent applications for papaya, 2001–12
•Table: Health claim submissions for papaya, 2009–12
•Table: Patent applications for seabuckthorn, 2000–12
•Table: Health claim submissions to EFSA for seabuckthorn, 2009–12
•Table: Clinical trials for seabuckthorn
•Table: Alternative names for superfruits
FIGURES
•Figure: Total oxygen radical absorbance capacity value, raw fruits
•Figure: ""High antioxidants"" is a leading health claim found on US food products, and has a strong association with superfruits
•Figure: Proportion of US consumers that say that they are familiar with specific superfruits
•Figure: Leading countries for superfruit food and drink launches by SKU, 2010–12
•Figure: A selection of blueberry-flavored products that have recently been launched
•Figure: A selection of pomegranate-flavored products that have recently been launched
•Figure: Food and drink launches containing chokeberry, 2009–12
•Figure: Chokeberry/aronia-flavored healthy indulgent foods
•Figure: Products containing jujube
•Figure: Food and drink launches containing jujube, 2009–12
•Figure: A selection of seabuckthorn-flavored products
•Figure: Food and drink launches containing seabuckthorn, 2009–12
•Figure: New product launches by industry and category (%), 2011
•Figure: New product launches by industry and category (%), 2011
•Figure: Superfruit tea and coffee launches
•Figure: Raspberry hazelnut vinaigrette and superfruit berry varieties of Wish Bone salad dressing
•Figure: Percentage of consumers who frequently consume products described as the following
•Figure: A word cloud showing superfruit patent applications: the bigger the word, the more patents the superfruit has had
•Figure: Tier one superfruits: number of patent applications related to food and drink
•Figure: Tier one superfruit patent activity by year, 2005–11
•Figure: Tier two superfruits: Number of patent applications related to food and drink
•Figure: Tier two superfruit patent activity by year, 2005–11
•Figure: Patents by therapeutic area
•Figure: Health claims related to superfruits submitted to EFSA, 2009–12
•Figure: Classification of superfruits by number of health claims submitted to EFSA, 2009–12
•Figure: Targeted therapeutic areas by health claim submissions, 2009–12
•Figure: Superfruits supported by clinical trials data (%), 2009–12
•Figure: Targeted therapeutic areas of clinical trials (%) ,2009–12
•Figure: Future of superfruits as indicated by manufacturing, research, health claims, and patents
•Figure: The future of the leading superfruits as indicated by health claim, patent and clinical trial activity
•Figure: Superfruits by health claim submissions and clinical data, 2009–12
•Figure: Superfruits by patent applications and to clinical trial data
•Figure: Superfruits by manufacturer interest and clinical data
•Figure: Key targeted therapeutic areas by superfruits
•Figure: Mangosteen NPD activity and patent, health claim, and clinical trial submissions
•Figure: Top five categories for new mangosteen food and drink launches, 2009–12
•Figure: Selection of mangosteen-flavored juice and ice cream
•Figure: Leading countries for mangosteen food and drink launches by SKU, 2009–12
•Figure: Papaya NPD activity and patent, health claim, and clinical trial submissions
•Figure: Leading countries for papaya food and drink launches by SKU, 2009–12
•Figure: Top five categories for new papaya food and drink launches, 2009–12
•Figure: A selection of juices and fruit products containing papaya
•Figure: Seabuckthorn NPD activity and patent, health claim, and clinical trial submissions
•Figure: Leading countries for seabuckthorn food and drink launches by SKU, 2009–12
•Figure: Top five categories for new seabuckthorn food and drink launches, 2009–12
•Figure: Selection of seabuckthorn jams and jellies, including Mondo Berry About the author •Disclaimer EXECUTIVE SUMMARY •The product launch landscape •The patent landscape •The health claims landscape •The clinical trials landscape Introduction •What is this report about? •Defining superfruits •Methodology •Report structure The product launch landscape •Summary •Introduction •Leading superfruit ingredients in NPD •Novel superfruit ingredients in NPD ?Chokeberry ?Jujube ?Seabuckthorn •New product category analysis •Claims analysis in new product launches ?Anti-infective ?Cardiovascular ?Digestive health ?Metabolic disorders •Conclusions The patent landscape •Summary •Introduction •Superfruit patent applications ?Tier one ?Tier two ?Tier three •Patents by therapeutic health area •Conclusions The health claims landscape •Summary •Introduction •EFSA now has stricter controls on functional food claims •Analysis of superfruit health claims from EFSA ?Scientific opinion •Leading therapeutic areas of claim submissions •Conclusions The clinical trials landscape •Summary •Introduction •Existing clinical evidence for superfruits •Most popular therapeutic areas for superfruit clinical trials •Conclusions Conclusions •Key superfruits •Current market landscape summary •Key targeted therapeutic areas •Superfruits: ones to watch ?Mangosteen ?Papaya ?Seabuckthorn •Conclusions Appendix •Methodology •Glossary/abbreviations •Bibliography/references TABLES •Table: Superfruits covered in this report •Table: Leading superfruits in new food and drinks, by percentage of superfruit launches, 2009–12 •Table: Leading superfruits in new food and drinks, by percentage of the 30 superfruits analyzed in this report, 2009–12 •Table: Targeted therapeutic areas by health claims on new product launches (%), 2009–12 •Table: Patent applications in 2010 related to tier one superfruits •Table: Acerola related patent applications, 2005–11 •Table: Tier three superfruits: No patent applications related to food and drink •Table: Digestive health and metabolic therapeutic areas related to superfruit patent applications •Table: EFSA negative opinions for superfruit health claims, 2011 •Table: Targeted therapeutic areas by health claims submitted to EFSA, 2009–12 •Table: Superfruit status by clinical trials, 2009–12 •Table: Targeted health areas of clinical trials, 2009–12 •Table: Future opportunities in superfruits as indicated by successful clinical trials, 2009–12 •Table: Patent applications for mangosteen, in food and drinks, 2005–12 •Table: Health claim applications for mangosteen, 2009–12 •Table: Clinical trials involving mangosteen, 2009–10 •Table: Patent applications for papaya, 2001–12 •Table: Health claim submissions for papaya, 2009–12 •Table: Patent applications for seabuckthorn, 2000–12 •Table: Health claim submissions to EFSA for seabuckthorn, 2009–12 •Table: Clinical trials for seabuckthorn •Table: Alternative names for superfruits FIGURES •Figure: Total oxygen radical absorbance capacity value, raw fruits •Figure: "High antioxidants" is a leading health claim found on US food products, and has a strong association with superfruits •Figure: Proportion of US consumers that say that they are familiar with specific superfruits •Figure: Leading countries for superfruit food and drink launches by SKU, 2010–12 •Figure: A selection of blueberry-flavored products that have recently been launched •Figure: A selection of pomegranate-flavored products that have recently been launched •Figure: Food and drink launches containing chokeberry, 2009–12 •Figure: Chokeberry/aronia-flavored healthy indulgent foods •Figure: Products containing jujube •Figure: Food and drink launches containing jujube, 2009–12 •Figure: A selection of seabuckthorn-flavored products •Figure: Food and drink launches containing seabuckthorn, 2009–12 •Figure: New product launches by industry and category (%), 2011 •Figure: New product launches by industry and category (%), 2011 •Figure: Superfruit tea and coffee launches •Figure: Raspberry hazelnut vinaigrette and superfruit berry varieties of Wish Bone salad dressing •Figure: Percentage of consumers who frequently consume products described as the following •Figure: A word cloud showing superfruit patent applications: the bigger the word, the more patents the superfruit has had •Figure: Tier one superfruits: number of patent applications related to food and drink •Figure: Tier one superfruit patent activity by year, 2005–11 •Figure: Tier two superfruits: Number of patent applications related to food and drink •Figure: Tier two superfruit patent activity by year, 2005–11 •Figure: Patents by therapeutic area •Figure: Health claims related to superfruits submitted to EFSA, 2009–12 •Figure: Classification of superfruits by number of health claims submitted to EFSA, 2009–12 •Figure: Targeted therapeutic areas by health claim submissions, 2009–12 •Figure: Superfruits supported by clinical trials data (%), 2009–12 •Figure: Targeted therapeutic areas of clinical trials (%) ,2009–12 •Figure: Future of superfruits as indicated by manufacturing, research, health claims, and patents •Figure: The future of the leading superfruits as indicated by health claim, patent and clinical trial activity •Figure: Superfruits by health claim submissions and clinical data, 2009–12 •Figure: Superfruits by patent applications and to clinical trial data •Figure: Superfruits by manufacturer interest and clinical data •Figure: Key targeted therapeutic areas by superfruits •Figure: Mangosteen NPD activity and patent, health claim, and clinical trial submissions •Figure: Top five categories for new mangosteen food and drink launches, 2009–12 •Figure: Selection of mangosteen-flavored juice and ice cream •Figure: Leading countries for mangosteen food and drink launches by SKU, 2009–12 •Figure: Papaya NPD activity and patent, health claim, and clinical trial submissions •Figure: Leading countries for papaya food and drink launches by SKU, 2009–12 •Figure: Top five categories for new papaya food and drink launches, 2009–12 •Figure: A selection of juices and fruit products containing papaya •Figure: Seabuckthorn NPD activity and patent, health claim, and clinical trial submissions •Figure: Leading countries for seabuckthorn food and drink launches by SKU, 2009–12 •Figure: Top five categories for new seabuckthorn food and drink launches, 2009–12 •Figure: Selection of seabuckthorn jams and jellies, including Mondo Berry
•The product launch landscape
•The patent landscape
•The health claims landscape
•The clinical trials landscape
Introduction
•What is this report about
•Defining superfruits
•Methodology
•Report structure
The product launch landscape
•Summary
•Introduction
•Leading superfruit ingredients in NPD
•Novel superfruit ingredients in NPD
Chokeberry
Jujube
Seabuckthorn
•New product category analysis
•Claims analysis in new product launches
Anti-infective
Cardiovascular
Digestive health
Metabolic disorders
•Conclusions
The patent landscape
•Summary
•Introduction
•Superfruit patent applications
Tier one
Tier two
Tier three
•Patents by therapeutic health area
•Conclusions
The health claims landscape
•Summary
•Introduction
•EFSA now has stricter controls on functional food claims
•Analysis of superfruit health claims from EFSA
Scientific opinion
•Leading therapeutic areas of claim submissions
•Conclusions
The clinical trials landscape
•Summary
•Introduction
•Existing clinical evidence for superfruits
•Most popular therapeutic areas for superfruit clinical trials
•Conclusions
Conclusions
•Key superfruits
•Current market landscape summary
•Key targeted therapeutic areas
•Superfruits: ones to watch
Mangosteen
Papaya
Seabuckthorn
•Conclusions
Appendix
•Methodology
•Glossary/abbreviations
•Bibliography/references
TABLES
•Table: Superfruits covered in this report
•Table: Leading superfruits in new food and drinks, by percentage of superfruit launches, 2009–12
•Table: Leading superfruits in new food and drinks, by percentage of the 30 superfruits analyzed in this report, 2009–12
•Table: Targeted therapeutic areas by health claims on new product launches (%), 2009–12
•Table: Patent applications in 2010 related to tier one superfruits
•Table: Acerola related patent applications, 2005–11
•Table: Tier three superfruits: No patent applications related to food and drink
•Table: Digestive health and metabolic therapeutic areas related to superfruit patent applications
•Table: EFSA negative opinions for superfruit health claims, 2011
•Table: Targeted therapeutic areas by health claims submitted to EFSA, 2009–12
•Table: Superfruit status by clinical trials, 2009–12
•Table: Targeted health areas of clinical trials, 2009–12
•Table: Future opportunities in superfruits as indicated by successful clinical trials, 2009–12
•Table: Patent applications for mangosteen, in food and drinks, 2005–12
•Table: Health claim applications for mangosteen, 2009–12
•Table: Clinical trials involving mangosteen, 2009–10
•Table: Patent applications for papaya, 2001–12
•Table: Health claim submissions for papaya, 2009–12
•Table: Patent applications for seabuckthorn, 2000–12
•Table: Health claim submissions to EFSA for seabuckthorn, 2009–12
•Table: Clinical trials for seabuckthorn
•Table: Alternative names for superfruits
FIGURES
•Figure: Total oxygen radical absorbance capacity value, raw fruits
•Figure: ""High antioxidants"" is a leading health claim found on US food products, and has a strong association with superfruits
•Figure: Proportion of US consumers that say that they are familiar with specific superfruits
•Figure: Leading countries for superfruit food and drink launches by SKU, 2010–12
•Figure: A selection of blueberry-flavored products that have recently been launched
•Figure: A selection of pomegranate-flavored products that have recently been launched
•Figure: Food and drink launches containing chokeberry, 2009–12
•Figure: Chokeberry/aronia-flavored healthy indulgent foods
•Figure: Products containing jujube
•Figure: Food and drink launches containing jujube, 2009–12
•Figure: A selection of seabuckthorn-flavored products
•Figure: Food and drink launches containing seabuckthorn, 2009–12
•Figure: New product launches by industry and category (%), 2011
•Figure: New product launches by industry and category (%), 2011
•Figure: Superfruit tea and coffee launches
•Figure: Raspberry hazelnut vinaigrette and superfruit berry varieties of Wish Bone salad dressing
•Figure: Percentage of consumers who frequently consume products described as the following
•Figure: A word cloud showing superfruit patent applications: the bigger the word, the more patents the superfruit has had
•Figure: Tier one superfruits: number of patent applications related to food and drink
•Figure: Tier one superfruit patent activity by year, 2005–11
•Figure: Tier two superfruits: Number of patent applications related to food and drink
•Figure: Tier two superfruit patent activity by year, 2005–11
•Figure: Patents by therapeutic area
•Figure: Health claims related to superfruits submitted to EFSA, 2009–12
•Figure: Classification of superfruits by number of health claims submitted to EFSA, 2009–12
•Figure: Targeted therapeutic areas by health claim submissions, 2009–12
•Figure: Superfruits supported by clinical trials data (%), 2009–12
•Figure: Targeted therapeutic areas of clinical trials (%) ,2009–12
•Figure: Future of superfruits as indicated by manufacturing, research, health claims, and patents
•Figure: The future of the leading superfruits as indicated by health claim, patent and clinical trial activity
•Figure: Superfruits by health claim submissions and clinical data, 2009–12
•Figure: Superfruits by patent applications and to clinical trial data
•Figure: Superfruits by manufacturer interest and clinical data
•Figure: Key targeted therapeutic areas by superfruits
•Figure: Mangosteen NPD activity and patent, health claim, and clinical trial submissions
•Figure: Top five categories for new mangosteen food and drink launches, 2009–12
•Figure: Selection of mangosteen-flavored juice and ice cream
•Figure: Leading countries for mangosteen food and drink launches by SKU, 2009–12
•Figure: Papaya NPD activity and patent, health claim, and clinical trial submissions
•Figure: Leading countries for papaya food and drink launches by SKU, 2009–12
•Figure: Top five categories for new papaya food and drink launches, 2009–12
•Figure: A selection of juices and fruit products containing papaya
•Figure: Seabuckthorn NPD activity and patent, health claim, and clinical trial submissions
•Figure: Leading countries for seabuckthorn food and drink launches by SKU, 2009–12
•Figure: Top five categories for new seabuckthorn food and drink launches, 2009–12
•Figure: Selection of seabuckthorn jams and jellies, including Mondo Berry About the author •Disclaimer EXECUTIVE SUMMARY •The product launch landscape •The patent landscape •The health claims landscape •The clinical trials landscape Introduction •What is this report about? •Defining superfruits •Methodology •Report structure The product launch landscape •Summary •Introduction •Leading superfruit ingredients in NPD •Novel superfruit ingredients in NPD ?Chokeberry ?Jujube ?Seabuckthorn •New product category analysis •Claims analysis in new product launches ?Anti-infective ?Cardiovascular ?Digestive health ?Metabolic disorders •Conclusions The patent landscape •Summary •Introduction •Superfruit patent applications ?Tier one ?Tier two ?Tier three •Patents by therapeutic health area •Conclusions The health claims landscape •Summary •Introduction •EFSA now has stricter controls on functional food claims •Analysis of superfruit health claims from EFSA ?Scientific opinion •Leading therapeutic areas of claim submissions •Conclusions The clinical trials landscape •Summary •Introduction •Existing clinical evidence for superfruits •Most popular therapeutic areas for superfruit clinical trials •Conclusions Conclusions •Key superfruits •Current market landscape summary •Key targeted therapeutic areas •Superfruits: ones to watch ?Mangosteen ?Papaya ?Seabuckthorn •Conclusions Appendix •Methodology •Glossary/abbreviations •Bibliography/references TABLES •Table: Superfruits covered in this report •Table: Leading superfruits in new food and drinks, by percentage of superfruit launches, 2009–12 •Table: Leading superfruits in new food and drinks, by percentage of the 30 superfruits analyzed in this report, 2009–12 •Table: Targeted therapeutic areas by health claims on new product launches (%), 2009–12 •Table: Patent applications in 2010 related to tier one superfruits •Table: Acerola related patent applications, 2005–11 •Table: Tier three superfruits: No patent applications related to food and drink •Table: Digestive health and metabolic therapeutic areas related to superfruit patent applications •Table: EFSA negative opinions for superfruit health claims, 2011 •Table: Targeted therapeutic areas by health claims submitted to EFSA, 2009–12 •Table: Superfruit status by clinical trials, 2009–12 •Table: Targeted health areas of clinical trials, 2009–12 •Table: Future opportunities in superfruits as indicated by successful clinical trials, 2009–12 •Table: Patent applications for mangosteen, in food and drinks, 2005–12 •Table: Health claim applications for mangosteen, 2009–12 •Table: Clinical trials involving mangosteen, 2009–10 •Table: Patent applications for papaya, 2001–12 •Table: Health claim submissions for papaya, 2009–12 •Table: Patent applications for seabuckthorn, 2000–12 •Table: Health claim submissions to EFSA for seabuckthorn, 2009–12 •Table: Clinical trials for seabuckthorn •Table: Alternative names for superfruits FIGURES •Figure: Total oxygen radical absorbance capacity value, raw fruits •Figure: "High antioxidants" is a leading health claim found on US food products, and has a strong association with superfruits •Figure: Proportion of US consumers that say that they are familiar with specific superfruits •Figure: Leading countries for superfruit food and drink launches by SKU, 2010–12 •Figure: A selection of blueberry-flavored products that have recently been launched •Figure: A selection of pomegranate-flavored products that have recently been launched •Figure: Food and drink launches containing chokeberry, 2009–12 •Figure: Chokeberry/aronia-flavored healthy indulgent foods •Figure: Products containing jujube •Figure: Food and drink launches containing jujube, 2009–12 •Figure: A selection of seabuckthorn-flavored products •Figure: Food and drink launches containing seabuckthorn, 2009–12 •Figure: New product launches by industry and category (%), 2011 •Figure: New product launches by industry and category (%), 2011 •Figure: Superfruit tea and coffee launches •Figure: Raspberry hazelnut vinaigrette and superfruit berry varieties of Wish Bone salad dressing •Figure: Percentage of consumers who frequently consume products described as the following •Figure: A word cloud showing superfruit patent applications: the bigger the word, the more patents the superfruit has had •Figure: Tier one superfruits: number of patent applications related to food and drink •Figure: Tier one superfruit patent activity by year, 2005–11 •Figure: Tier two superfruits: Number of patent applications related to food and drink •Figure: Tier two superfruit patent activity by year, 2005–11 •Figure: Patents by therapeutic area •Figure: Health claims related to superfruits submitted to EFSA, 2009–12 •Figure: Classification of superfruits by number of health claims submitted to EFSA, 2009–12 •Figure: Targeted therapeutic areas by health claim submissions, 2009–12 •Figure: Superfruits supported by clinical trials data (%), 2009–12 •Figure: Targeted therapeutic areas of clinical trials (%) ,2009–12 •Figure: Future of superfruits as indicated by manufacturing, research, health claims, and patents •Figure: The future of the leading superfruits as indicated by health claim, patent and clinical trial activity •Figure: Superfruits by health claim submissions and clinical data, 2009–12 •Figure: Superfruits by patent applications and to clinical trial data •Figure: Superfruits by manufacturer interest and clinical data •Figure: Key targeted therapeutic areas by superfruits •Figure: Mangosteen NPD activity and patent, health claim, and clinical trial submissions •Figure: Top five categories for new mangosteen food and drink launches, 2009–12 •Figure: Selection of mangosteen-flavored juice and ice cream •Figure: Leading countries for mangosteen food and drink launches by SKU, 2009–12 •Figure: Papaya NPD activity and patent, health claim, and clinical trial submissions •Figure: Leading countries for papaya food and drink launches by SKU, 2009–12 •Figure: Top five categories for new papaya food and drink launches, 2009–12 •Figure: A selection of juices and fruit products containing papaya •Figure: Seabuckthorn NPD activity and patent, health claim, and clinical trial submissions •Figure: Leading countries for seabuckthorn food and drink launches by SKU, 2009–12 •Figure: Top five categories for new seabuckthorn food and drink launches, 2009–12 •Figure: Selection of seabuckthorn jams and jellies, including Mondo Berry
Loading...
Loading...
Our guarantees
Price Guarantee
Our prices are competitive, and to ensure you get the most attractive deal available, we'll do our very best to match any price in the unlikely event you can find the same product for less elsewhere.
All we ask for is reasonable proof of the report being currently available at the lower price.
If you do find a lower price, contact Claire Cole direct by telephone on +44 (0)1527 573 738, 1-866-545-5878 Toll-Free from the US, alternatively email us here.
Satisfaction Guarantee
Many resellers don't offer refunds full stop. We're different. If you are dissatisfied with your purchase let us know within 5 working days. If we are unable to address the problem to your satisfaction we will give you a full refund.
